Genome & Company Market Cap

Genome & Company has a market cap or net worth of 245.30 billion as of March 9, 2026. Its market cap has increased by 181.10% in one year.

Market Cap

245.30B

Enterprise Value

234.43B

Revenue

25.95B

Ranking

n/a

PE Ratio

n/a

Stock Price

7,030.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 245.30B, an increase of 241.27%. That is a compound annual growth rate of 18.60%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	245.30B	2.90%
Dec 30, 2025	238.38B	179.77%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ISU Abxis	204.82B
Bio Solution	244.14B
Prestige Biologics	200.60B
ABION	254.54B
Ensol Biosciences	192.90B
Kangstem Biotech	189.05B
TiumBio	186.10B
QuadMedicine	182.57B

Market Cap Rankings